Victoza (liraglutide) was approved June 17, 2019, for pediatric patients 10 years of age and older for the treatment of type 2 糖尿病. This is the first non-insulin drug approved to treat type 2 diabetes in children since metformin was approved for pediatric patients in 2000.
结肠镜检查和胃镜检查的完整指南: 期望什么和视频资源
结肠镜检查和胃镜检查的完整指南: 期望和视频资源现代医学提供了高效的诊断工具，用于检测消化道的疾病. 最重要的两个过程是结肠镜检查 阅读更多…